Shareholders at Nordion (NYSE:NDZ) voted this month to approved an acquisition proposal after suitor Sterigenics boosted its offer to $13 per share, for a total value of $805 million.
Mergers & Acquisitions
Cantel Medical to pay $27M for endoscope reprocessor PuriCore
Cantel Medical (NYSE:CMN) said it agreed to put up $26.9 million in cash to acquire PuriCore International, a British endoscope reprocessing company.
The case for early deals in med tech
By Amy Siegel, S2N Health
Medtronic mum on potential Smith & Nephew buy
Report: Is Medtronic looking to buy Smith & Nephew?
Stentys to acquire Cappella Peel Away’s stent delivery device
Stentys said it agreed to pay an unspecified amount to acquire Cappella Peel Away and its "novel" stent delivery system.
Princeton, N.J.- and Paris-based Stentys said it plans to integrate the technology into the delivery system for its line of bare-metal and drug-eluting stents, aiming to have the new system on the market in 2015.
Allergan proxy war gets ugly as Valeant aims to unseat the board
Medical Action Industries closes $79M Medegen, patient care business sale
Medical Action Industries (NSDQ:MDCI) said it closed the $79 million sale of its Medegen Medical Products subsidiary and parts of its patient care business to Inteplast Group’s Medira Inc.
Sterigenics boosts Nordion bid to $805M
St. Jude Medical closes $455M CardioMEMS buy
St. Jude Medical (NYSE:STJ) wasted no time in closing its acquisition of CardioMEMS, days after the FDA approved the Champion HF implantable heart monitor, saying it plans to begin a "strategic" launch of the device in the U.S.